ArticleJournal for immunotherapy of cancer2021

Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.

Stefano Pierini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.